- Home
- LEE vs NSPR Comparison
LEE vs NSPR Comparison
Compare LEE & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEE
- NSPR
- Stock Information
- Founded
- LEE 1890
- NSPR 2005
- Country
- LEE United States
- NSPR Israel
- Employees
- LEE N/A
- NSPR N/A
- Industry
- LEE Newspapers/Magazines
- NSPR Medical/Dental Instruments
- Sector
- LEE Consumer Discretionary
- NSPR Health Care
- Exchange
- LEE Nasdaq
- NSPR Nasdaq
- Market Cap
- LEE N/A
- NSPR 75.6M
- IPO Year
- LEE N/A
- NSPR N/A
- Fundamental
- Price
- LEE $10.38
- NSPR $2.69
- Analyst Decision
- LEE
- NSPR Strong Buy
- Analyst Count
- LEE 0
- NSPR 2
- Target Price
- LEE N/A
- NSPR $4.75
- AVG Volume (30 Days)
- LEE 18.3K
- NSPR 67.4K
- Earning Date
- LEE 05-01-2025
- NSPR 03-12-2025
- Dividend Yield
- LEE N/A
- NSPR N/A
- EPS Growth
- LEE N/A
- NSPR N/A
- EPS
- LEE N/A
- NSPR N/A
- Revenue
- LEE $600,264,000.00
- NSPR $7,009,000.00
- Revenue This Year
- LEE N/A
- NSPR $50.18
- Revenue Next Year
- LEE N/A
- NSPR $159.56
- P/E Ratio
- LEE N/A
- NSPR N/A
- Revenue Growth
- LEE N/A
- NSPR 12.96
- 52 Week Low
- LEE $7.57
- NSPR $1.81
- 52 Week High
- LEE $19.63
- NSPR $3.80
- Technical
- Relative Strength Index (RSI)
- LEE 56.33
- NSPR 39.79
- Support Level
- LEE $9.53
- NSPR $2.57
- Resistance Level
- LEE $10.74
- NSPR $2.78
- Average True Range (ATR)
- LEE 0.62
- NSPR 0.20
- MACD
- LEE 0.30
- NSPR -0.01
- Stochastic Oscillator
- LEE 72.52
- NSPR 17.72
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.